People · Operator

BARRY S. FOGEL

Named in public records as an officer, director or promoter · active 2010–2014 · Other Health Care, Other

2
Companies
3
Filings
$7.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Synchroneuron Inc.Other Health CareSeed$5.5M$86.8M2012
Pointright Inc.OtherSeed$1.5M$27.9M2010
Operator network

BARRY S. FOGEL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Isaac S. Cheng · 2 companies · 1 sharedIsaac S. ChengMARC R. COTE · 2 companies · 1 sharedMARC R. COTEWilliam D. Kerns · 2 companies · 1 sharedWilliam D. KernsGERALD R. CHAN · 1 companies · 1 sharedGERALD R. CHANGerald S. Chan · 1 companies · 1 sharedGerald S. ChanISAAC R. CHENG · 1 companies · 1 sharedISAAC R. CHENGMarc S. Cote · 1 companies · 1 sharedMarc S. CoteWILLLIAM D. KERNS · 1 companies · 1 sharedWILLLIAM D. KERNSDean A. Staley · 1 companies · 1 sharedDean A. StaleyJames L. Roosevelt, Jr. · 1 companies · 1 sharedJames L. Roosevel…Peter L. Falb · 1 companies · 1 sharedPeter L. FalbRodrigo Navarro-Banzer · 1 companies · 1 sharedRodrigo Navarro-B…Vincent S. Mor · 1 companies · 1 sharedVincent S. MorSynchroneuron Inc. · $5.5M raisedSynchroneuron Inc.Pointright Inc. · $1.5M raisedPointright Inc.BARRY S. FOGELBF
BARRY S. FOGEL Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside BARRY S. FOGEL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
William D. Kerns12
Isaac S. Cheng12
MARC R. COTE12
Gerald S. Chan11
Marc S. Cote11
Vincent S. Mor11
Dean A. Staley11
James L. Roosevelt, Jr.11
Rodrigo Navarro-Banzer11
GERALD R. CHAN11
Peter L. Falb11
ISAAC R. CHENG11
WILLLIAM D. KERNS11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.